2025 · 1st Quarter (Jan 1 - Mar 31)

GRIFOLS SHARED SERVICES NORTH AMERICA, INC.

Filed by HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP).

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 15, 2025
Income: $80,000.00
Expenses: Not reported
Registrant: HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)
Client: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.
Filing UUID: aa471d3b-b0e2-4048-8d42-bcda51c38e8c
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

H.R. 1476 & S. 694, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 1143, Medicare IVIG Access Enhancement Act of 2025. H.R. 2343 , John W. Walsh Alpha-1 Home Infusion Act of 2025. H.R. 2172, Preserving Patient Access to Home Infusion Act. Issues related to the implementation of P.L. 117-169, The Inflation Reduction Act.

Literal federal measure citations: H.R. 1476, S. 694, H.R. 1143, H.R. 2343, H.R. 2172

IMM · Immigration

Issues related to immigration policy.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.